Suicidality at Focal Epilepsy Diagnosis Predicts Treatment Resistance

Managing focal epilepsy relies heavily on antiseizure medications, yet approximately 30% of patients ultimately develop drug-resistant epilepsy despite optimal pharmacological therapy [1, 2]. Identifying which patients will fail standard medical management remains a persistent clinical challenge, often requiring years of trial and error before alternative interventions like resective surgery or neuromodulation (a technique that alters nerve activity through targeted electrical stimulation) are considered [3]. Recent evidence suggests that psychiatric comorbidities, which frequently co-occur with seizure disorders, may serve as early clinical markers for a more severe disease trajectory and subsequent medication refractoriness [4, 5]. A recent prospective study demonstrates how specific psychiatric symptoms present at the time of initial diagnosis might predict future treatment resistance, potentially helping clinicians stratify patient risk earlier in the disease course [6].